Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Anti-HIV drug removes personal responsibility

I would argue that Pre-exposure Prophylaxis is a solution which removes personal responsibility in relation to the transmission of HIV, increases the practice of unprotected sexual behaviour and will, ultimately, be responsible for widespread liver disease among gay populations in 10-15 years from now.

Published
20 April 2017
From
Irish Times
Open letter to Gilead Sciences about PrEP by EATG and the PrEP in Europe Initiative

Please read and share this letter signed by the European AIDS Treatment Group and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs. It requests Gilead Sciences to surrender their patent of Truvada® or otherwise make it possible for Truvada or generic equivalents of it to be offered at greatly reduced prices to all European health care systems so that it can be used as HIV pre-exposure prophylaxis (PrEP).

Published
18 April 2017
From
EATG / PrEP in Europe
HIV notifications down 16 per cent in Queensland compared to same period in 2016

There have been 48 HIV notifications in Queensland until April 2, compared with 57 to the same period in 2016.

Published
18 April 2017
From
Brisbane Times
The real sex lives of gay men - GMFA's biggest survey

GMFA has just conducted its biggest-ever sex survey for the 150th edition of its resource FS. Ian Howley, Chief Executive of GMFA, said: “With over 3,000 responses it gives a fascinating snapshot of the kind of sex that gay and bisexual men in the UK are having, what they enjoy and what they are doing, or not doing, to maintain their sexual health.”

Published
13 April 2017
From
GMFA
Sex, drugs and activism: making HIV treatment as prevention available in the UK

The Scottish pathway to the PrEP policy decision has been very different to that of England.

Published
13 April 2017
From
Sociology Lens
Behaviour change interventions in HIV prevention: is there still a place for them?

A meta-analysis of studies of brief interventions to reduce HIV risk behaviour in HIV-negative gay men has concluded that there is evidence that such techniques did have

Published
12 April 2017
By
Gus Cairns
PrEP marketing campaigns get homoerotic. It’s about time.

Shirtless lucha libre Mexican wrestlers diving into bed are part of a colorful new print ad campaign promoting “health and sex” for Gilead Sciences, the pharma maker of HIV prevention drug Truvada.

Published
11 April 2017
From
Queerty
PrEP is approved in Scotland

The Scottish Medicines Consortium (SMC) today announced that it had accepted tenofovir disoproxil/emtricitabine (TDF/FTC – Truvada) for use within the Scottish National Health Service

Published
10 April 2017
By
Gus Cairns
Update on PrEP Impact trial in England

The trial protocol is complete, trial participant eligibility criteria have been endorsed by experts in the field and by community representatives, and independent peer review has been conducted. The Medicines and Healthcare products Regulatory Agency (MHRA) has been consulted about trial categorisation and a relevant opinion received. Submission for ethics committee approval is imminent. Our aim is to have the trial started by the summer of 2017.

Published
10 April 2017
From
Public Health England
The large fall in HIV diagnoses in London gay men is real and thanks to combination prevention, not just PrEP

The number of new HIV diagnoses in gay men attending five key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England told

Published
06 April 2017
By
Roger Pebody
← First12345...525Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.